Showing 1 - 20 results of 4,757 for search '"Liver cancer', query time: 0.26s Refine Results
  1. 1

    Genomic Profiling of Liver Cancer by Ju-Seog Lee

    Published 2013-12-01
    “…Development of liver cancers is driven largely by genomic alterations that deregulate signaling pathways, influencing growth and survival of cancer cells. …”
    Get full text
    Article
  2. 2
  3. 3
  4. 4

    Cancer-associated fibroblasts: multidimensional players in liver cancer by Yanyun Pan, Yuangang Qiu, Xinbin Zhou, Wei Mao, Xiaoming Xu

    Published 2025-04-01
    “…Recent studies using advanced single-cell RNA sequencing technology (scRNAseq) combined with multiple genetically engineered mouse models have identified diverse CAF subpopulations in the premalignant liver microenvironment (PME) of hepatocellular carcinoma (HCC) and TME of intrahepatic cholangiocarcinoma (ICC), providing a deeper understanding of the exact roles of each CAF subpopulation in cancer development. …”
    Get full text
    Article
  5. 5

    Nanotechnology for the Diagnosis and Treatment of Liver Cancer by Cai Y, Wang W, Jiao Q, Hu T, Ren Y, Su X, Li Z, Feng M, Liu X, Wang Y

    Published 2024-12-01
    “…Although there are many clinical treatments available for liver cancer, the cure rate is still very low, and now researchers have begun to explore new aspects of liver cancer treatment, and nanotechnology has shown great potential for improving diagnostic accuracy and therapeutic efficacy and is therefore a promising treatment option. …”
    Get full text
    Article
  6. 6
  7. 7

    Comparative immunohistochemical characteristics of hepatocellular, cholangiocellular cancer and liver metastases of pancreatic cancer in puncture trephine biopsy of the liver by V. A. Tumanskiy, M. D. Zubko

    Published 2015-10-01
    “…Differential immunohistochemical parameters of primary liver cancer and liver metastases of ductal pancreatic cancer (DPC) were studied in puncture trephine biopsy of the liver of 23 patients with hepatocellular carcinoma (HCC), 2 patients combined hepato-cholangiocellular cancer (CHCC), 15 patients cholangiocellular cancer (CCC) and 12 patients with metastatic DPC. …”
    Get full text
    Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Metabolism and Immune Suppressive Response in Liver Cancer by Patrizio Caini, Vinicio Carloni

    Published 2025-06-01
    “…This review focuses on a relatively underexplored aspect of liver cancer immunology, the immunosuppressive role of tumor-associated macrophages (TAMs) and regulatory T cells (Tregs) driven by metabolic alterations and how these mechanisms contribute to the suppression of effective anti-tumor immune responses.…”
    Get full text
    Article
  13. 13
  14. 14

    PROTEOMIC COMPARISON OF EXTRACELLULAR MATRIX WITHIN LIVER METASTASES OF COLORECTAL CANCER AND NORMAL LIVER by ARSENIY E. Yuzhalin, RUTH J. Muschel

    Published 2018-03-01
    “…To investigate the composition of extracellular matrix proteins in colorectal cancer liver metastases and normal liver. Materials and Methods. …”
    Get full text
    Article
  15. 15
  16. 16

    Understanding crosstalk between the gut and liver microbiome: pathogenesis to therapeutic approaches in liver cancer by Himanshi Goyal, Kaneez Fatima, Jyotdeep Kaur

    Published 2025-07-01
    “…Abstract HCC is the most common primary liver cancer, ranking as the sixth most prevalent cancer globally and the third leading cause of cancer-related deaths. …”
    Get full text
    Article
  17. 17
  18. 18
  19. 19
  20. 20